108 related articles for article (PubMed ID: 304785)
1. Some immunological effects of penicillamine.
Chen DM; Di Sabato G; Field L; Gallo AA; Harshman S
Clin Exp Immunol; 1977 Nov; 30(2):317-22. PubMed ID: 304785
[TBL] [Abstract][Full Text] [Related]
2. Studies of D-penicillamine (3): immunomodulating effects of D-penicillamine.
Otomo S; Nakaike S; Tsuji I; Mori C; Ohzeki M
Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):313-20. PubMed ID: 6820351
[TBL] [Abstract][Full Text] [Related]
3. Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acid derivatives. II. Immunosuppressive effects.
Takeshita K; Fukazawa I; Nakaike S; Kameo K; Tomisawa K; Otomo S; Aihara H
Drugs Exp Clin Res; 1988; 14(5):311-8. PubMed ID: 3219994
[TBL] [Abstract][Full Text] [Related]
4. Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse.
Hurtenbach U; Gleichmann H; Nagata N; Gleichmann E
J Immunol; 1987 Jul; 139(2):411-6. PubMed ID: 3110270
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
[TBL] [Abstract][Full Text] [Related]
6. [Basis of immunosuppressive effect of D-penecillamine].
Schumacher K
Internist (Berl); 1975 Oct; 16(10):460-5. PubMed ID: 1107252
[No Abstract] [Full Text] [Related]
7. [Studies of D-penicillamine (4) : effects on antibody formation (author's transl)].
Otomo S; Takeshita K; Koda H; Ohzeki M
Nihon Yakurigaku Zasshi; 1981 Jul; 78(1):45-56. PubMed ID: 6796481
[TBL] [Abstract][Full Text] [Related]
8. Influence of D-penicillamine on the immune response of mice.
Schumacher K; Maerker-Alzer G; Schaaf W
Arzneimittelforschung; 1975 Apr; 25(4):600-3. PubMed ID: 1098678
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acids. Immunomodulating effects.
Takeshita K; Fukazawa I; Futaki N; Kameo K; Tomisawa K; Otomo S; Aihara H
Arzneimittelforschung; 1988 Apr; 38(4):537-42. PubMed ID: 3041971
[TBL] [Abstract][Full Text] [Related]
10. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
Lipsky PE
Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
[TBL] [Abstract][Full Text] [Related]
11. Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer.
Nagata N; Hurtenbach U; Gleichmann E
J Immunol; 1986 Jan; 136(1):136-42. PubMed ID: 2415613
[TBL] [Abstract][Full Text] [Related]
12. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
Sheĭtanov I
Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
[TBL] [Abstract][Full Text] [Related]
13. Modulation of human antibody production in vitro by D-penicillamine and CuSO4: inhibition of helper T cell function.
Lipsky PE
J Rheumatol Suppl; 1981; 7():69-73. PubMed ID: 6971939
[TBL] [Abstract][Full Text] [Related]
14. The effect of prenatal exposure to the n-butylester of 2,4-dichlorophenoxyacetic acid (2,4-D) on the immune response in mice.
Blakley BR; Blakley PM
Teratology; 1986 Feb; 33(1):15-20. PubMed ID: 3488604
[TBL] [Abstract][Full Text] [Related]
15. Impaired T-dependent immune response in L-dopa treated BALB/c mice.
Boukhris W; Kouassi E; Descotes J; Cordier G; Revillard JP
J Clin Lab Immunol; 1987 Aug; 23(4):185-9. PubMed ID: 2959786
[TBL] [Abstract][Full Text] [Related]
16. [D-penicillamine: mechanism of cellular action and induced autoimmune diseases].
Meyer O
Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):15-20. PubMed ID: 2939541
[TBL] [Abstract][Full Text] [Related]
17. SA96: an immunopharmacological profile in vitro.
Yamamoto I; Ohmori H; Okimura T
Int J Tissue React; 1982; 4(1):1-8. PubMed ID: 7200957
[TBL] [Abstract][Full Text] [Related]
18. Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells.
Francus T; Klein RF; Staiano-Coico L; Becker CG; Siskind GW
J Immunol; 1988 Mar; 140(6):1823-9. PubMed ID: 3257988
[TBL] [Abstract][Full Text] [Related]
19. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
Chiba K; Nishimura T; Hashimoto Y
J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
[TBL] [Abstract][Full Text] [Related]
20. The effects of Boicil on some immunocompetent cells. II. In vitro and in vivo modulation of the mouse cellular and humoral immune response.
Olinescu A; Hristescu S; Poliopol M; Agache F; Kerek F
Arch Roum Pathol Exp Microbiol; 1987; 46(2):147-58. PubMed ID: 3502686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
